Good correlation of HPV DNA test between self-collected vaginal and clinician-collected cervical samples by the oligonucleotide microarray

被引:23
作者
Seo, Sang-Soo
Song, Yong-Sang
Kim, Jae-Weon
Park, Noh-Hyun
Kang, Soon-Beom
Lee, Hyo-Pyo
机构
[1] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Canc Res Inst, Seoul 110744, South Korea
[2] Natl Canc Ctr, Ctr Uterine Canc, Goyang 411351, Gyeonggi Do, South Korea
关键词
self-collection; vaginal samples; HPV DNA test; HPVDNAchip (TM); cervical cancer;
D O I
10.1016/j.ygyno.2005.11.030
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives. To evaluate the efficacy of self-collected vaginal samples for high-risk HPV detection by the HPV oligonucleotide microarray method (HPVDNAChip (TM)). Methods. One hundred and eighteen patients with abnormal Pap smears were included. Self-collected vaginal and clinician-collected cervical samples for HPV testing were obtained. The result of the HPV DNA test was compared with the histopathological diagnosis or colposcopic finding. Results. Of the 118 patients, 42 (35.6%) had >= cervical intraepithelial neoplasia (CIN) III lesions. Using the HPVDNAChip (TM), high-risk types of HPV were detected in 38 of these 42 patients (90.5%) with the self-collected vaginal samples and in 37 of 42 (88.1%) with the clinician-collected cervical samples. The agreement of HPVDNAchip (TM) results between self- and clinician-collected samples was very good (kappa = 0.81) with a 93.2% concordance rate. Multiple HPV infections were found in 17 of 88 (19.3%) HPV-positive clinician-collected cervical samples. The rate of multiple HPV infection tended to decrease as the degree of pathologic classification increased. Conclusion. Using the HPVDNAchip (TM) to assay for HPV infection, results from self-collected vaginal samples were compatible with those from clinician-collected cervical samples. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:67 / 73
页数:7
相关论文
共 47 条
  • [1] Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray method
    An, HJ
    Cho, NH
    Lee, SY
    Kim, IH
    Lee, C
    Kim, SJ
    Mun, MS
    Kim, SH
    Jeong, JK
    [J]. CANCER, 2003, 97 (07) : 1672 - 1680
  • [2] Genotyping of 22 human papillomavirus types by DNA chip in Korean women: Comparison with cytologic diagnosis
    Cho, NH
    An, HJ
    Jeong, JK
    Kang, S
    Kim, JW
    Kim, YT
    Park, TK
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2003, 188 (01) : 56 - 62
  • [3] CLARKE EA, 1979, LANCET, V2, P1
  • [4] Carcinogenicity of human papillomaviruses
    Cogliano, V
    Baan, R
    Straif, K
    Grosse, Y
    Secretan, B
    El Ghissassi, F
    [J]. LANCET ONCOLOGY, 2005, 6 (04) : 204 - 204
  • [5] Coutlee F, 1997, J MED VIROL, V51, P42, DOI 10.1002/(SICI)1096-9071(199701)51:1<42::AID-JMV7>3.0.CO
  • [6] 2-S
  • [7] A systematic review of the role of human papilloma virus (HPV) testing within a cervical screening programme: summary and conclusions
    Cuzick, J
    Sasieni, P
    Davies, P
    Adams, J
    Normand, C
    Frater, A
    van Ballegooijen, M
    van den Akker-van Marle, E
    [J]. BRITISH JOURNAL OF CANCER, 2000, 83 (05) : 561 - 565
  • [8] Primary cervical cancer screening by self-sampling of human papillomavirus DNA in internal medicine outpatient clinics
    Dannecker, C
    Siebert, U
    Thaler, CJ
    Kiermeir, D
    Hepp, H
    Hillemanns, P
    [J]. ANNALS OF ONCOLOGY, 2004, 15 (06) : 863 - 869
  • [9] The acceptability of self-collected samples for HPV testing vs. the pap test as alternatives in cervical cancer screening
    Dzuba, IG
    Díaz, EY
    Allen, B
    Leonard, YF
    Ponce, ECL
    Shah, KV
    Bishai, D
    Lorincz, A
    Ferris, D
    Turnbull, B
    Avila, MH
    Salmerón, J
    [J]. JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE, 2002, 11 (03): : 265 - 274
  • [10] METAANALYSIS OF PAP TEST ACCURACY
    FAHEY, MT
    IRWIG, L
    MACASKILL, P
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1995, 141 (07) : 680 - 689